| BALANCE SHEET COMPONENTS |
BALANCE SHEET COMPONENTS The following tables present financial information of certain consolidated balance sheets components: | | | | | | | | | | | | | As of December 31, | (in thousands) | 2025 | | 2024 | Property and equipment, net | | | | Laboratory equipment | $ | 54,113 | | | $ | 53,550 | | Computer hardware | 3,993 | | | 4,682 | | Furniture and fixtures | 2,515 | | | 2,577 | | Computer software | 1,072 | | | 1,072 | | Leasehold improvements | 59,769 | | | 59,764 | | | Construction-in-process | 804 | | | 1,296 | | Property and equipment, gross | 122,266 | | | 122,941 | | Less accumulated depreciation and amortization | (70,453) | | | (53,880) | | | Total property and equipment, net | $ | 51,813 | | | $ | 69,061 | |
| | | | | | | | | | | | | As of December 31, | | (in thousands) | 2025 | | 2024 | | Accounts Receivable, net | | | | | Trade accounts receivable, gross | $ | 21,899 | | | $ | 24,099 | | | Allowance for credit losses | (3,604) | | | (3,787) | | | Total accounts receivable, net | $ | 18,295 | | | $ | 20,312 | |
| | | | | | | | | | | | | As of December 31, | | (in thousands) | 2025 | | 2024 | | Accrued liabilities | | | | Accrued compensation expenses | $ | 36,299 | | | $ | 34,530 | | Accrued clinical studies and research and development expenses | 15,656 | | | 13,027 | | Accrued legal and professional service expenses | 3,650 | | | 2,966 | | Accrued other expenses | 8,340 | | | 6,718 | | | Total accrued liabilities | $ | 63,945 | | | $ | 57,241 | |
|